Rankings
▼
Calendar
INMB Q1 2017 Earnings — INmune Bio, Inc. Revenue & Financial Results | Market Cap Arena
INMB
INmune Bio, Inc.
$38M
Q1 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$119,450
Net Income
$30,550
EPS (Diluted)
$0.01
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$144,031
Free Cash Flow
-$144,031
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$0
Total Liabilities
$0
Stockholders' Equity
-$149,203
Cash & Equivalents
-$141,660
← FY 2017
All Quarters
Q2 2017 →
